Fondazione Irccs Ca' Granda, Ospedale Maggiore Policlinico
Clinical trials sponsored by Fondazione Irccs Ca' Granda, Ospedale Maggiore Policlinico, explained in plain language.
-
Cancer drug combo tested for rare skin cancer – but study never started
Disease control TerminatedThis study aimed to test a combination of two drugs, pembrolizumab and lenvatinib, in people with classic Kaposi sarcoma that had not responded to prior chemotherapy. The goal was to see if the combination could shrink tumors better than standard chemotherapy. However, the study …
Phase: PHASE2 • Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Disease control
Last updated May 08, 2026 12:00 UTC
-
Which hormone combo do women prefer for endometriosis?
Symptom relief OngoingThis study looks at two different hormone treatments for endometriosis, a condition that causes pain and fertility problems. Researchers want to find out which combination of progestin and natural estrogen makes women more satisfied after 6 months. The study involves 138 women wh…
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC
-
Massive hospital study reveals hidden kidney danger
Knowledge-focused OngoingThis study looks at medical records of 43,000 hospitalized patients to find out how often acute kidney injury (AKI) happens during a hospital stay. Researchers will also see how AKI affects patients' chances of recovery, readmission, and survival. The goal is to better understand…
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated May 13, 2026 15:59 UTC